Altimmune Inc (LTS:0A4C) Stock News, Headlines & Updates
Altimmune Inc Stock News from GuruFocus
- 1
- 2
- 3
May 30, 2024
Shareholders that lost money on Altimmune, Inc.(ALT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
PRNewswire • 5:00am
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Equinix, Harbor Diversified, Altimmune, and UnitedHealth and Encourages Investors to Contact the Firm
Marketwired • 8:00pm
May 29, 2024
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
PRNewswire • 4:00pm
Class Action Filed Against Altimmune, Inc. (ALT) - July 5, 2024 Deadline to Join -- Contact Levi & Korsinsky
Marketwired • 12:00pm
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Altimmune, Inc. (ALT)
Marketwired • 11:00am
Altimmune to Participate at Two Upcoming Investor Conferences
Marketwired • 7:00am
Altimmune to Present Clinical Data from Pemvidutide at Upcoming EASL International Liver Congressâ„¢ 2024
Marketwired • 7:00am
The Gross Law Firm Notifies Shareholders of Altimmune, Inc.(ALT) of a Class Action Lawsuit and an Upcoming Deadline
PRNewswire • 5:00am
May 28, 2024
ALTIMMUNE, INC. (NASDAQ: ALT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Altimmune, Inc. Investors of Upcoming Deadline
Marketwired • 2:00pm
Shareholders of Altimmune, Inc. Should Contact The Gross Law Firm Before July 5, 2024 to Discuss Your Rights -- ALT
Marketwired • 1:00pm
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines -- ALT
Marketwired • 10:00am
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Marketwired • 3:00am
May 27, 2024
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- ALT
Marketwired • 10:00am
May 24, 2024
DEADLINE ALERT for ALT, AXTI, HRBR, and LI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Marketwired • 12:00pm
DEADLINE ALERT for ALT, AXTI, HRBR, LI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Marketwired • 10:00am
May 23, 2024
ALT Stockholders: Robbins LLP Reminds ALT Stockholders of Securities Fraud Class Action Against Altimmune, Inc.
Marketwired • 5:00pm
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PRNewswire • 12:00pm
Altimmune, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT
PRNewswire • 5:00am
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
PRNewswire • 8:00pm
May 22, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PRNewswire • 1:00pm
ROSEN, A TOP RANKED LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- ALT
Marketwired • 1:00pm
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Altimmune, Inc. (ALT)
Marketwired • 10:00am
May 21, 2024
ALT INVESTOR NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- ALT
Business Wire • 3:00pm
Altimmune, Inc. Sued for Securities Law Violations -- Investors Should Contact Levi & Korsinsky for More Information -- ALT
Marketwired • 2:00pm
Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM)
PRNewswire • 9:00am
The Gross Law Firm Notifies Altimmune, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ALT
PRNewswire • 5:00am
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Marketwired • 3:00am
May 20, 2024
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PRNewswire • 5:00pm
Robbins LLP Urges Altimmune, Inc. (ALT) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
Business Wire • 3:00pm
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines -- ALT
Marketwired • 11:00am
May 17, 2024
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- ALT
Marketwired • 6:00pm
Levi & Korsinsky Reminds Altimmune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 5, 2024 -- ALT
Marketwired • 1:00pm
DEADLINE ALERT for ALT, AXTI, HRBR, and LI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Marketwired • 12:00pm
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Altimmune, Inc. (ALT)
Marketwired • 10:00am
May 16, 2024
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PRNewswire • 4:01pm
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PRNewswire • 12:00pm
Investors who lost money on Altimmune, Inc. (ALT) should contact The Gross Law Firm about pending Class Action - ALT
Marketwired • 12:00pm
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
PRNewswire • 10:00pm
May 15, 2024
- 1
- 2
- 3
Show
Entries
Headlines
Total 0- 1
No recent news
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers